This funding supports continuation of the US Influenza Vaccine Effectiveness Network to improve vaccine effectiveness against influenza and other respiratory pathogens. Funded activities include annual vaccine effectiveness surveillance, electronic acute respiratory illness monitoring, household transmission studies, and immunogenicity research. Applicants must apply for either Component A or B, with optional Components C and D available depending on the primary component chosen. Funding amounts vary by component, supporting multi-site research efforts.
Eligible applicants include state, county, city, and special district governments; public and private institutions of higher education; Native American tribal governments and organizations; public housing authorities; nonprofits with or without 501(c)(3) status; and for-profit organizations excludin
